| Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation CC Chu, N Ali, P Karagiannis, P Di Meglio, A Skowera, L Napolitano, ... Journal of Experimental Medicine 209 (5), 935-945, 2012 | 257 | 2012 |
| Targeting folate receptor alpha for cancer treatment A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ... Oncotarget 7 (32), 52553, 2016 | 206 | 2016 |
| AllergoOncology: the role of IgE‐mediated allergy in cancer E Jensen‐Jarolim, G Achatz, MC Turner, S Karagiannis, F Legrand, ... Allergy 63 (10), 1255-1266, 2008 | 201 | 2008 |
| IgG4 subclass antibodies impair antitumor immunity in melanoma P Karagiannis, AE Gilbert, DH Josephs, N Ali, T Dodev, L Saul, I Correa, ... The Journal of Clinical Investigation 123 (4), 1457-1474, 2013 | 145 | 2013 |
| Comparison of IgE and IgG antibody‐dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma HJ Gould, GA Mackay, SN Karagiannis, CM O'Toole, PJ Marsh, BE Daniel, ... European journal of immunology 29 (11), 3527-3537, 1999 | 139 | 1999 |
| Diverse matrix metalloproteinase functions regulate cancer amoeboid migration JL Orgaz, P Pandya, R Dalmeida, P Karagiannis, B Sanchez-Laorden, ... Nature communications 5 (1), 1-13, 2014 | 132 | 2014 |
| IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells SN Karagiannis, MG Bracher, J Hunt, N McCloskey, RL Beavil, AJ Beavil, ... The Journal of Immunology 179 (5), 2832-2843, 2007 | 123 | 2007 |
| Activity of human monocytes in IgE antibody‐dependent surveillance and killing of ovarian tumor cells SN Karagiannis, Q Wang, N East, F Burke, S Riffard, MG Bracher, ... European journal of immunology 33 (4), 1030-1040, 2003 | 122 | 2003 |
| Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells P Karagiannis, J Singer, J Hunt, SKE Gan, SM Rudman, ... Cancer immunology, immunotherapy 58 (6), 915-930, 2009 | 103 | 2009 |
| Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... Frontiers in immunology 10, 453, 2019 | 94 | 2019 |
| TGF-β-induced transcription sustains amoeboid melanoma migration and dissemination G Cantelli, JL Orgaz, I Rodriguez-Hernandez, P Karagiannis, O Maiques, ... Current biology 25 (22), 2899-2914, 2015 | 80 | 2015 |
| A tool kit for rapid cloning and expression of recombinant antibodies TS Dodev, P Karagiannis, AE Gilbert, DH Josephs, H Bowen, LK James, ... Scientific reports 4 (1), 1-10, 2014 | 77 | 2014 |
| Epidemiological associations of allergy, IgE and cancer DH Josephs, JF Spicer, CJ Corrigan, HJ Gould, SN Karagiannis Clinical & Experimental Allergy 43 (10), 1110-1123, 2013 | 75 | 2013 |
| Endocytosis and recycling of the complex between CD23 and HLA‐DR in human B cells SN Karagiannis, JK Warrack, KH Jennings, PR Murdock, G Christie, ... Immunology 103 (3), 319-331, 2001 | 75 | 2001 |
| Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells SN Karagiannis, MG Bracher, RL Beavil, AJ Beavil, J Hunt, N McCloskey, ... Cancer Immunology, Immunotherapy 57 (2), 247-263, 2008 | 74 | 2008 |
| An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment L Halim, M Romano, R McGregor, I Correa, P Pavlidis, N Grageda, ... Cell reports 20 (3), 757-770, 2017 | 64 | 2017 |
| Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma KM Ilieva, I Correa, DH Josephs, P Karagiannis, IU Egbuniwe, ... Molecular cancer therapeutics 13 (12), 2769-2783, 2014 | 64 | 2014 |
| Evaluating biomarkers in melanoma P Karagiannis, M Fittall, SN Karagiannis Frontiers in oncology 4, 383, 2015 | 62 | 2015 |
| Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis M Bracher, HJ Gould, BJ Sutton, D Dombrowicz, SN Karagiannis Journal of immunological methods 323 (2), 160-171, 2007 | 62 | 2007 |
| Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment M Georgouli, C Herraiz, E Crosas-Molist, B Fanshawe, O Maiques, ... Cell 176 (4), 757-774. e23, 2019 | 59 | 2019 |
Debra JosephsAcademic Clinical Lecturer in Translational Cancer Immunology at KCL and StR in Medical OncologyVerified email at kcl.ac.uk
